Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04410029 · ClinicalTrials.gov registry record · NA

Evaluation of a Decision Aid for Early Pregnancy Loss

A NA study of Early Pregnancy Loss, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT04410029: Completed NA study of Early Pregnancy Loss, sponsored by University of Pennsylvania.

NCT04410029 is a NA study of Early Pregnancy Loss that has completed, run by University of Pennsylvania. The registered enrollment target is 60 participants, below the 204-participant average among 3 other Early Pregnancy Loss trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04410029, a NA study of Early Pregnancy Loss, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

This study aims to determine the effect of the Healthwise decision aid on shared decision making in women undergoing management of early pregnancy loss.

Primary Outcome

Low-literacy version of Decision Conflict Scale

Conditions Studied

Interventions

  • OTHER Healthwise Decision Aid
  • OTHER Control informational handout

Study Locations (1)

Pennsylvania

  • Hospital of the University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2020-07-29
Est. Completion 2021-03-25
Phase NA
University of Pennsylvania

1,423 total trials

What the finished NCT04410029 record still lists

NCT04410029 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 204-participant average among 3 other Early Pregnancy Loss trials with a reported enrollment target (71% lower).

The record links to 1 condition, with Early Pregnancy Loss appearing as the primary indexed condition, and to 2 interventions - of which Healthwise Decision Aid is the first listed.

NCT04410029 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04410029 about?

NCT04410029 is a clinical study titled "Evaluation of a Decision Aid for Early Pregnancy Loss". This study aims to determine the effect of the Healthwise decision aid on shared decision making in women undergoing management of early pregnancy loss.

What is the current status of trial NCT04410029?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2020-07-29. Estimated completion is 2021-03-25.

What conditions does trial NCT04410029 study?

This clinical trial studies the following conditions: Early Pregnancy Loss.

What interventions are being tested in trial NCT04410029?

The interventions under investigation include: Healthwise Decision Aid (OTHER), Control informational handout (OTHER).

Who is sponsoring clinical trial NCT04410029?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04410029 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Early Pregnancy Loss

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04410029, the US trial registry maintained by the National Library of Medicine. NCT04410029 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.